Key result
Tailored CVD risk assessment in SLE targets both traditional and non-traditional atherosclerosis risk factors.
This review highlights the need for tailored cardiovascular disease risk assessment and management strategies in patients with systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) patients have a significantly increased risk of developing cardiovascular disease (CVD). Despite the implementation of preventive measures and treatment of lipid disorders, as well as reduced use of glucocorticoids, CVD remains one of the leading causes of death in this patient group. It is crucial to develop an appropriate CVD risk assessment strategy that considers the distinctive characteristics of this patient population. This paper provides a comprehensive analysis of the methods used to assess CVD risk in SLE patients. It also presents effective strategies for the reduction of the effects of traditional and non-traditional risk factors for atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Suszek et al. (2025) conducted a review in Systemic lupus erythematosus (SLE). Cardiovascular disease risk assessment and treatment strategies was evaluated. Cardiovascular disease risk assessment in systemic lupus erythematosus requires tailored approaches to address traditional and non-traditional atherosclerosis risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: